Ritesh P. Daya

Hamilton, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

The Effect of PAOPA, a Novel Allosteric Modulator of Dopamine D2 Receptors, on Signaling Proteins Following Sub-Chronic Administration in Rats.

The Effect of PAOPA, a Novel Allosteric Modulator of Dopamine D2 Receptors, on Signaling Proteins Following Sub-Chronic Administration in Rats.

Journal: Current molecular pharmacology
Published: March 24, 2020

Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer's Disease and Related Dementias and Strategic Implications for Stakeholders.

Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer's Disease and Related Dementias and Strategic Implications for Stakeholders.

Journal: Journal of Alzheimer's disease : JAD
Published: July 01, 2019

The Dopamine Allosteric Agent, PAOPA, Demonstrates Therapeutic Potential in the Phencyclidine NMDA Pre-clinical Rat Model of Schizophrenia.

The Dopamine Allosteric Agent, PAOPA, Demonstrates Therapeutic Potential in the Phencyclidine NMDA Pre-clinical Rat Model of Schizophrenia.

Journal: Frontiers in behavioral neuroscience
Published: September 08, 2018

Reduced expression of synapsin II in a chronic phencyclidine preclinical rat model of schizophrenia.

Reduced expression of synapsin II in a chronic phencyclidine preclinical rat model of schizophrenia.

Journal: Synapse (New York, N.Y.)
Published: July 22, 2018

Intranasal delivery of antipsychotic drugs.

Intranasal delivery of antipsychotic drugs.

Journal: Schizophrenia research
Published: April 14, 2016

Improvements and important considerations for the 5-choice serial reaction time task-An effective measurement of visual attention in rats.

Improvements and important considerations for the 5-choice serial reaction time task-An effective measurement of visual attention in rats.

Journal: Journal of neuroscience methods
Published: February 11, 2016

Brain Targeting of a Water Insoluble Antipsychotic Drug Haloperidol via the Intranasal Route Using PAMAM Dendrimer.

Brain Targeting of a Water Insoluble Antipsychotic Drug Haloperidol via the Intranasal Route Using PAMAM Dendrimer.

Journal: Molecular pharmaceutics
Published: July 31, 2015

Effects of MK-801 treatment across several pre-clinical analyses including a novel assessment of brain metabolic function utilizing PET and CT fused imaging in live rats.

Effects of MK-801 treatment across several pre-clinical analyses including a novel assessment of brain metabolic function utilizing PET and CT fused imaging in live rats.

Journal: Neuropharmacology
Published: June 17, 2013

Synapsin II gene expression in the dorsolateral prefrontal cortex of brain specimens from patients with schizophrenia and bipolar disorder: effect of lifetime intake of antipsychotic drugs.

Synapsin II gene expression in the dorsolateral prefrontal cortex of brain specimens from patients with schizophrenia and bipolar disorder: effect of lifetime intake of antipsychotic drugs.

Journal: The pharmacogenomics journal
Published: August 28, 2012

Behavioral effects of non-viral mediated RNA interference of synapsin II in the medial prefrontal cortex of the rat.

Behavioral effects of non-viral mediated RNA interference of synapsin II in the medial prefrontal cortex of the rat.

Journal: Schizophrenia research
Published: December 08, 2011

Alpha-phenyl-N-tert-butylnitrone prevents oxidative stress in a haloperidol-induced animal model of tardive dyskinesia: investigating the behavioural and biochemical changes.

Alpha-phenyl-N-tert-butylnitrone prevents oxidative stress in a haloperidol-induced animal model of tardive dyskinesia: investigating the behavioural and biochemical changes.

Journal: Brain research
Published: May 24, 2011
Showing 1-11 of 11

Last Updated: 09/26/2026